Drug
SHR-A2009
SHR-A2009 is a pharmaceutical drug with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
3
50%
Ph phase_1
3
50%
Phase Distribution
3
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
3(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
6
all time
Status Distribution
Active(4)
Completed(1)
Other(1)
Detailed Status
Recruiting2
Not yet recruiting2
Completed1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (50.0%)
Phase 23 (50.0%)
Trials by Status
recruiting233%
completed117%
not_yet_recruiting233%
unknown117%
Recent Activity
2 active trials
Showing 5 of 6
recruitingphase_2
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
NCT06649331
not_yet_recruitingphase_1
A Phase Ib Study of HS-10504 Combined Therapy in NSCLC
NCT07414953
completedphase_1
The Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors
NCT05394818
recruitingphase_2
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
NCT05594095
not_yet_recruitingphase_2
Clinical Study of SHR-A1921 or SHR-A2009 in Previously Treated Advanced NSCLC
NCT06465238
Clinical Trials (6)
Showing 6 of 6 trials
NCT06649331Phase 2
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
NCT07414953Phase 1
A Phase Ib Study of HS-10504 Combined Therapy in NSCLC
NCT05394818Phase 1
The Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors
NCT05594095Phase 2
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
NCT06465238Phase 2
Clinical Study of SHR-A1921 or SHR-A2009 in Previously Treated Advanced NSCLC
NCT05114759Phase 1
A Phase I Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6